PYRAZOLOPYRIDINE CARBOXAMIDE DERIVATIVE AND PHOSPHODIESTERASE (PDE) INHIBITOR COMPRISING THE DERIVATIVE
申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:EP2058310A1
公开(公告)日:2009-05-13
A novel pyrazolopyridine carboxamide derivative is provided that is useful as a pharmaceutical drug having phosphodiesterase inhibitory activity.
The pyrazolopyridine carboxamide derivative is represented by the following general formula (1):
(Example: 2-ethyl-7-methoxypyrazolo[1,5-a]pyridine-4-carboxylic acid (3,5-dichloropyridin-4-yl)amide).
本研究提供了一种新型吡唑吡啶羧酰胺衍生物,可用作具有磷酸二酯酶抑制活性的药物。
吡唑吡啶羧酰胺衍生物由以下通式(1)表示:
(例:2-乙基-7-甲氧基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺)。